Ever Source Wealth Advisors, LLC Nuvation Bio Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,414 shares of NUVB stock, worth $2,997. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,414
Previous 11,424
87.62%
Holding current value
$2,997
Previous $30,000
93.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NUVB
# of Institutions
167Shares Held
156MCall Options Held
4.6KPut Options Held
154K-
Decheng Capital LLC Menlo Park, CA26MShares$55 Million12.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$34.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.4MShares$32.6 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$27.7 Million47.43% of portfolio
-
Laurion Capital Management LP New York, NY9.87MShares$20.9 Million0.45% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $461M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...